Skip to main content
Fig. 8 | BMC Complementary Medicine and Therapies

Fig. 8

From: Integrated investigation and discovery of therapeutic targets for 3-hydroxybakuchiol against diabetes based on molecular docking studies and cell experiments

Fig. 8

A Cell viability at different concentrations of HYD on HepG2 cells. B Effect of HYD on glucose consumption in insulin resistance model (HepG2 cells). HepG2 cells were exposed to 100 nM insulin and 25 mmol/L glucose only or with different concentrations of HYD for 24 h. The values were presented as the mean ± SD, with a sample size (n) of 6 for each group. Group comparisons were conducted using a one-way analysis of variance. ### denotes P < 0.001, vs. the control group; * denotes P < 0.05, *** denotes P < 0.001, vs. the model group. # denotes the comparison of the model group with the normal group; * denotes the comparison of the drug group with the model group

Back to article page